About Us

Dedicated to The Upstream Tool Industry of Biomedicine

About us：

Genetimes Excell International Holdings Limited (GTHK) is a subsidiary of Genetimes Technology Inc., a private, high-tech company which is supporting the fields of biomedical science and biotechnology. Since its incorporation from June 18, 1998 in Shanghai, China, Genetimes has grown over steadily. Genetimes delivers products in every aspects of biological researches, including molecular biology reagents, biochemicals, immunological reagents, clinical diagnostic kits, pharmaceutical industry raw materials, scientific instruments, consumables, etc. These products are used widely in academic fields and industrial applications, from basic biomedical research to disease diagnosis, from emerging new biotechnology to pharmaceutical production and healthcare products manufacture. 

In order to provide the best possible products and services to our customers in China, Genetimes built a complete distribution network from the ground up, with subdivisions, branch offices and sales representatives in all major cities and regions. Genetimes has over 3,000 customers in universities, research institutes, hospitals, pharmaceutical and biotechnology companies and other industrial companies.

Our Culture：

Our Mission

To provide superior products and services for biomedical research and the improvement of human health, to become a leader in biological science and biotechnology, and to help our shareholders, customers and employees achieve success.

Our Motto

Surpass expectations in the pursuit of excellence.

Principles dedication, innovation, teamwork, and superior, proactive customer care.

Our Core Values

Speed Up Life Sciences

Fuel Well-being for All

Our Location：

Genetimes ExCell
Internationals Holding Limited
Scientific Solutions & Services
Headquarters
Our Sales Representatives
Order & Support
Human Resources

Awards & Recognition：

2013
Found
2014
Won the title of "Innovation and Entrepreneurship Plan talent", "Taicang Science and Technology Innovation Leading Talent", and "Suzhou Innovation and Entrepreneurship Leading Talent"
2016
The serum factory company in Uruguay was put into operation;
2017
Won the title of "National High-tech Enterprise"
2018
R&D center in Taicang was completed, serum-free medium project was launched;
2019
Five types of serum-free media have been launched, with proprietary intellectual property right; Recognized as "Jiangsu Province Cell Therapy Medium and Gene Detection Reagent Engineering Technology Research Center";
2020
Obtained nearly 100 million of A-financing; Recognized as "the engineering research center of CD serum-free culture medium for biopharmaceutical, cell therapy and other fields in Jiangsu Province";
2021
serum-free medium GMP workshop put into production, Obtained more than 100 million of B-financing; Won the title of "2021 Provincial Enterprise Technology Center";
2022
Biosafety Analytical Kits GMP workshop put into production, serum and serum-free production plan expanded; Won the title of "National “Little Giant” Enterprise"; Obtained more than 100 million of B+-financing;
2023
The second mfg site of Serum in Uruguay named ARTICA was put into operation.
2024
Artica has been included in the "Registration List of Biomaterials Enterprises for Beef Blood Products Exported to China"